3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
6
Colonic Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pancreatitis, Acute Necrotizing
1
Pancreatic Fistula
1
Pancreatic Cyst
1
Neoplasm Metastasis
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Krukenberg Tumor
1
Hyperthermia
1
Fallopian Tube Neoplasms
1
Eye Neoplasms
1
Endometrial Neoplasms
1
Complex Ovarian Cyst
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Burkitt Lymphoma
1
Anastomotic Leak
1
Abdominal Injuries
1
Abdominal Abscess
1
Interventions
Carboplatin
87
Paclitaxel
77
Bevacizumab
38
Topotecan
23
liposomal doxorubicin
22
Gemcitabine
22
Taxes
21
Cisplatin
17
Drug Therapy
14
Docetaxel
14
Cyclophosphamide
14
pembrolizumab
13
Immunoglobulin G
12
Disulfides
12
veliparib
8
rucaparib
8
mirvetuximab soravtansine
8
niraparib
7
Albumin-Bound Paclitaxel
7
sargramostim
6
Filgrastim
6
Erlotinib Hydrochloride
6
Doxorubicin
6
pazopanib
5
Granulocyte-Macrophage Colony-Stimulating Factor
5
Chemotherapy, Adjuvant
5
CP protocol
5
trebananib
4
temsirolimus
4
olaparib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Fallopian Tube Neoplasms
×
Laparotomy
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts